Vascular Biogenics Overview

Vascular Biogenics Operating Income

Operating Income for VBLT.

Quarterly Operating Income

$-5380000.00

↓ 723.41% YoY

As of Jun 30, 2024

Annual Operating Income (TTM)

$-64136000.00

↑ 8.33% YoY

Trailing 12 months ending Jun 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin